| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 105.13B | 116.01B | 175.85B | 179.08B | 135.21B | 102.90B |
| Gross Profit | 8.44B | 9.25B | 14.70B | 17.00B | 12.91B | 9.34B |
| EBITDA | 1.45B | 1.67B | 5.23B | 7.37B | 4.53B | 2.04B |
| Net Income | 578.00M | 506.00M | 3.19B | 4.71B | 2.82B | 1.25B |
Balance Sheet | ||||||
| Total Assets | 80.26B | 80.05B | 99.81B | 98.83B | 88.95B | 73.49B |
| Cash, Cash Equivalents and Short-Term Investments | 29.68B | 31.61B | 13.39B | 10.93B | 10.71B | 17.70B |
| Total Debt | 9.30B | 10.15B | 17.57B | 17.95B | 11.28B | 4.43B |
| Total Liabilities | 27.99B | 27.51B | 43.69B | 46.26B | 37.00B | 23.14B |
| Stockholders Equity | 51.42B | 51.70B | 55.33B | 51.86B | 51.37B | 49.72B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 31.64B | 4.55B | -1.04B | -11.90B | -4.91B |
| Operating Cash Flow | 0.00 | 31.72B | 4.70B | -905.00M | -11.63B | -4.53B |
| Investing Cash Flow | 0.00 | -3.09B | 105.00M | 9.00M | -407.00M | -714.00M |
| Financing Cash Flow | 0.00 | -11.56B | -2.76B | 682.00M | 4.25B | -1.23B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥185.59B | 4.98 | 17.09% | 2.94% | 9.67% | 45.58% | |
76 Outperform | ¥22.01B | 10.49 | ― | 3.83% | 41.87% | 167.99% | |
74 Outperform | ¥49.00B | 13.51 | ― | 4.12% | -4.88% | -26.05% | |
65 Neutral | ¥29.53B | -17.27 | ― | 5.16% | 1.71% | -29.37% | |
64 Neutral | ¥13.89B | 25.64 | ― | 4.62% | -2.98% | 4.56% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | ¥32.58B | 40.99 | 1.55% | 1.34% | -34.13% | -31.24% |